Profil
Richard Benarous is the founder of two companies.
In 2000, he founded Cytomics Pharmaceuticals SA. In 2006, he founded CellVir SAS and held the title of Chief Technology Officer in 2009.
Dr. Benarous was also a Professor at the Massachusetts Institute of Technology.
Ehemalige bekannte Positionen von Richard Benarous
| Unternehmen | Position | Ende |
|---|---|---|
CellVir SAS
 CellVir SAS Pharmaceuticals: OtherHealth Technology CellVir SAS develops anti-retrovirals based on novel therapeutics. Its research is focused on HIV disease. The company was founded by Richard Benarous, Richard Platford, Armand Frydman, E. Thomas Bader, and Jean Deregnaucourt on March 20, 2006 and is headquartered in Evry, France. | Gründer | 04.06.2012 |
Cytomics Pharmaceuticals SA
 Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Gründer | 10.10.2011 |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cytomics Pharmaceuticals SA
Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Health Technology |
CellVir SAS
CellVir SAS Pharmaceuticals: OtherHealth Technology CellVir SAS develops anti-retrovirals based on novel therapeutics. Its research is focused on HIV disease. The company was founded by Richard Benarous, Richard Platford, Armand Frydman, E. Thomas Bader, and Jean Deregnaucourt on March 20, 2006 and is headquartered in Evry, France. | Health Technology |
